Alpha Teknova (TKNO) Revenue & Revenue Breakdown
Alpha Teknova Revenue Highlights
Latest Revenue (Y)
$36.68M
Latest Revenue (Q)
$9.61M
Main Segment (Y)
Lab Essentials
Main Geography (Y)
UNITED STATES
Alpha Teknova Revenue by Period
Alpha Teknova Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $36.68M | -11.43% |
| 2022-12-31 | $41.42M | 12.27% |
| 2021-12-31 | $36.89M | 17.88% |
| 2020-12-31 | $31.30M | 55.75% |
| 2019-12-31 | $20.09M | - |
Alpha Teknova generated $36.68M in revenue during NA 2023, up -11.43% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Alpha Teknova Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $9.61M | 3.49% |
| 2024-03-31 | $9.29M | 18.09% |
| 2023-12-31 | $7.87M | -3.70% |
| 2023-09-30 | $8.17M | -29.13% |
| 2023-06-30 | $11.53M | 26.38% |
| 2023-03-31 | $9.12M | 15.59% |
| 2022-12-31 | $7.89M | -26.20% |
| 2022-09-30 | $10.69M | -8.54% |
| 2022-06-30 | $11.69M | 4.87% |
| 2022-03-31 | $11.15M | 10.26% |
| 2021-12-31 | $10.11M | 7.64% |
| 2021-09-30 | $9.39M | 12.98% |
| 2021-06-30 | $8.31M | -8.43% |
| 2021-03-31 | $9.08M | -10.62% |
| 2020-12-31 | $10.16M | 13.06% |
| 2020-09-30 | $8.98M | 48.64% |
| 2020-06-30 | $6.04M | -1.11% |
| 2020-03-31 | $6.11M | - |
Alpha Teknova generated $9.61M in revenue during Q2 2024, up 3.49% compared to the previous quarter, and up 105.41% compared to the same period a year ago.
Alpha Teknova Revenue Breakdown
Alpha Teknova Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Other Product | $1.15M | $1.20M | $1.39M |
| Clinical Solutions | $6.74M | $8.45M | $6.79M |
| Lab Essentials | $28.80M | $31.77M | $27.18M |
| Sample Transport | - | $6.00K | $1.53M |
Alpha Teknova's latest annual revenue breakdown by segment (product or service), as of Dec 23: Lab Essentials (78.51%), Clinical Solutions (18.37%), and Other Product (3.12%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Product | $411.00K | $306.00K | $300.00K | $298.00K | $293.00K | $255.00K | $185.00K | $303.00K | $354.00K | $354.00K | $432.00K | $434.00K | $227.00K |
| Clinical Solutions | $1.56M | $1.72M | $879.00K | $597.00K | $3.65M | $1.61M | $772.00K | $919.00K | $2.94M | $3.81M | $2.44M | $1.69M | $1.59M |
| Lab Essentials | $7.64M | $7.27M | $6.69M | $7.27M | $7.58M | $7.26M | $6.93M | $9.47M | $8.39M | $6.97M | $6.74M | $7.20M | $6.46M |
| Sample Transport | - | - | - | - | - | - | - | - | $6.00K | $495.00K | $73.00K | $37.00K | - |
Alpha Teknova's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Lab Essentials (79.45%), Clinical Solutions (16.28%), and Other Product (4.28%).
Alpha Teknova Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| UNITED STATES | $35.00M | $40.10M | - |
| Non-US | $1.68M | $1.32M | - |
| U S | - | - | $35.81M |
| Non Us | - | - | $1.08M |
Alpha Teknova's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (95.41%), and Non-US (4.59%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $9.23M | $8.87M | $7.37M | $7.83M | $11.07M | $8.73M | $7.61M | $10.38M | $11.29M | $10.82M | $9.11M | $8.06M | - |
| Non-US | $386.00K | $420.00K | $495.00K | $342.00K | $452.00K | $395.00K | $277.00K | $308.00K | $405.00K | $327.00K | $278.00K | - | - |
| Non Us | - | - | - | - | - | - | - | - | - | - | $192.00K | $252.00K | - |
| U S | - | - | - | - | - | - | - | - | - | - | $9.92M | - | - |
Alpha Teknova's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (95.99%), and Non-US (4.01%).
Alpha Teknova Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| COLL | Collegium Pharmaceutical | $566.77M | $144.92M |
| ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
| ORGO | Organogenesis | $433.14M | $130.23M |
| PROC | Procaps Group | $409.92M | $118.41M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| LFCR | Lifecore Biomedical | $128.26M | $35.70M |
| TKNO | Alpha Teknova | $36.68M | $9.61M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| RGC | Regencell Bioscience | - | - |
TKNO Revenue FAQ
What is Alpha Teknova’s yearly revenue?
Alpha Teknova's yearly revenue for 2023 was $36.68M, representing a decrease of -11.43% compared to 2022. The company's yearly revenue for 2022 was $41.42M, representing an increase of 12.27% compared to 2021. TKNO's yearly revenue for 2021 was $36.89M, representing an increase of 17.88% compared to 2020.
What is Alpha Teknova’s quarterly revenue?
Alpha Teknova's quarterly revenue for Q2 2024 was $9.61M, a 3.49% increase from the previous quarter (Q1 2024), and a -16.60% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $9.29M, a 18.09% increase from the previous quarter (Q4 2023), and a 1.85% increase year-over-year (Q1 2023). TKNO's quarterly revenue for Q4 2023 was $7.87M, a -3.70% decrease from the previous quarter (Q3 2023), and a -0.30% decrease year-over-year (Q4 2022).
What is Alpha Teknova’s revenue growth rate?
Alpha Teknova's revenue growth rate for the last 3 years (2021-2023) was -0.57%, and for the last 5 years (2019-2023) was 82.56%.
What are Alpha Teknova’s revenue streams?
Alpha Teknova's revenue streams in c 23 are Other Product, Clinical Solutions, and Lab Essentials. Other Product generated $1.15M in revenue, accounting 3.12% of the company's total revenue, down -4.26% year-over-year. Clinical Solutions generated $6.74M in revenue, accounting 18.37% of the company's total revenue, down -20.21% year-over-year. Lab Essentials generated $28.8M in revenue, accounting 78.51% of the company's total revenue, down -9.35% year-over-year.
What is Alpha Teknova’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Alpha Teknova was Lab Essentials. This segment made a revenue of $28.8M, representing 78.51% of the company's total revenue.